Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-08

AUTHORS

David C. Smith, John Powderly, James J. Lee, Dale R. Shepard, Johan Wallin, Archana Chaudhary, Grace Yi Chao, Wee Teck Ng, Malcolm I. Mitchell, Gerrit Grau, Raffael Kurek, Patricia LoRusso

ABSTRACT

PURPOSE: Necitumumab is a second-generation, recombinant, human immunoglobulin G1 monoclonal antibody that blocks the ligand binding site of the epidermal growth factor receptor. The primary objective of this phase 2 study, conducted in accordance with International Conference on Harmonisation E14 guidance, was to determine the effect of necitumumab treatment on QT/QTc interval in patients with advanced solid tumors. METHODS: Patients received necitumumab monotherapy at an absolute dose of 800 mg, once per week for each 6-week cycle. Triplicate electrocardiogram readings were taken at pretreatment (baseline) and then weekly at multiple timepoints that were time-matched with blood samples to determine necitumumab concentrations. RESULTS: Seventy-five patients received treatment. Overall, the upper bound of the two-sided 90 % confidence interval for mean change from baseline in QTc in cycle 1 did not exceed 10 ms. No patients had a mean QTcF interval >500 ms, and no patients had an increase of >60 ms. Necitumumab concentration-QTc analysis also showed that necitumumab is unlikely to cause QTc prolongation. CONCLUSIONS: The results demonstrate lack of effect of necitumumab on the QTc interval in heavily pretreated patients with advanced solid tumors, suggesting that QT prolongation is not a major safety concern for necitumumab at the recommended therapeutic dose. The safety profile was consistent with the known safety profile of necitumumab. More... »

PAGES

271-280

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-016-3074-y

DOI

http://dx.doi.org/10.1007/s00280-016-3074-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010329834

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27312733


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electrocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Long QT Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "University of Michigan, 1500 E Medical Center Drive SPC 5913, 48109, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "David C.", 
        "id": "sg:person.015706665604.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015706665604.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Carolina BioOncology Institute", 
          "id": "https://www.grid.ac/institutes/grid.488747.0", 
          "name": [
            "Carolina BioOncology Institute, Huntersville, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Powderly", 
        "givenName": "John", 
        "id": "sg:person.01072502357.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072502357.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pittsburgh", 
          "id": "https://www.grid.ac/institutes/grid.21925.3d", 
          "name": [
            "University of Pittsburgh, Pittsburgh, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "James J.", 
        "id": "sg:person.0606761270.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606761270.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cleveland Clinic", 
          "id": "https://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Cleveland Clinic Foundation, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shepard", 
        "givenName": "Dale R.", 
        "id": "sg:person.011040661365.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011040661365.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Eli Lilly and Company, Solna, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wallin", 
        "givenName": "Johan", 
        "id": "sg:person.015161041725.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015161041725.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chaudhary", 
        "givenName": "Archana", 
        "id": "sg:person.015756422325.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015756422325.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chao", 
        "givenName": "Grace Yi", 
        "id": "sg:person.012404342477.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012404342477.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Eil Lilly-NUS, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ng", 
        "givenName": "Wee Teck", 
        "id": "sg:person.0632743041.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632743041.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.418786.4", 
          "name": [
            "Eli Lilly and Company, Windlesham, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitchell", 
        "givenName": "Malcolm I.", 
        "id": "sg:person.01053122403.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053122403.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.435900.b", 
          "name": [
            "Eli Lilly and Company, Bad Homburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grau", 
        "givenName": "Gerrit", 
        "id": "sg:person.011443672525.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011443672525.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.435900.b", 
          "name": [
            "Eli Lilly and Company, Bad Homburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kurek", 
        "givenName": "Raffael", 
        "id": "sg:person.0602351767.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602351767.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale University", 
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Yale University, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LoRusso", 
        "givenName": "Patricia", 
        "id": "sg:person.012616064757.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012616064757.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/cpt.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001089388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vascn.2008.04.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001315364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-2425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005648183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ott.s68558", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006743397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0091270007307881", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010317390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra0707704", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013325677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0091270011407191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015032956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40264-015-0300-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025247766", 
          "https://doi.org/10.1007/s40264-015-0300-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00021-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025750831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/1040-8428(94)00144-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027064147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bcp.12443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029424155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200767170-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034984109", 
          "https://doi.org/10.2165/00003495-200767170-00008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0163-7258(98)00045-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036450024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-013-2146-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039786526", 
          "https://doi.org/10.1007/s00280-013-2146-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40264-013-0047-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046942550", 
          "https://doi.org/10.1007/s40264-013-0047-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-011-0003-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051296505", 
          "https://doi.org/10.1007/s13300-011-0003-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.2011.595709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067588473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.2015.1055243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067589107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5414/cp202337", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072834501"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08", 
    "datePublishedReg": "2016-08-01", 
    "description": "PURPOSE: Necitumumab is a second-generation, recombinant, human immunoglobulin G1 monoclonal antibody that blocks the ligand binding site of the epidermal growth factor receptor. The primary objective of this phase 2 study, conducted in accordance with International Conference on Harmonisation E14 guidance, was to determine the effect of necitumumab treatment on QT/QTc interval in patients with advanced solid tumors.\nMETHODS: Patients received necitumumab monotherapy at an absolute dose of 800\u00a0mg, once per week for each 6-week cycle. Triplicate electrocardiogram readings were taken at pretreatment (baseline) and then weekly at multiple timepoints that were time-matched with blood samples to determine necitumumab concentrations.\nRESULTS: Seventy-five patients received treatment. Overall, the upper bound of the two-sided 90\u00a0% confidence interval for mean change from baseline in QTc in cycle 1 did not exceed 10\u00a0ms. No patients had a mean QTcF interval >500\u00a0ms, and no patients had an increase of >60\u00a0ms. Necitumumab concentration-QTc analysis also showed that necitumumab is unlikely to cause QTc prolongation.\nCONCLUSIONS: The results demonstrate lack of effect of necitumumab on the QTc interval in heavily pretreated patients with advanced solid tumors, suggesting that QT prolongation is not a major safety concern for necitumumab at the recommended therapeutic dose. The safety profile was consistent with the known safety profile of necitumumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-016-3074-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "78"
      }
    ], 
    "name": "Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors", 
    "pagination": "271-280", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "31365caad092f7b8d0c654eddcd4d22b859a4974b0fe0d40bf9b880e1eb0e6ab"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27312733"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-016-3074-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010329834"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-016-3074-y", 
      "https://app.dimensions.ai/details/publication/pub.1010329834"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87109_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00280-016-3074-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-016-3074-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-016-3074-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-016-3074-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-016-3074-y'


 

This table displays all metadata directly associated to this object as RDF triples.

282 TRIPLES      21 PREDICATES      60 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-016-3074-y schema:about N06a3773d3517421db6cc19772f929a05
2 N1a6228dbbc9449f788626581c7377a09
3 N210c77c77d164fdd91e8c0af462bc673
4 N347ca019343f4aae8b6560d97c9ecf06
5 N3ba3d8a351a74389b754ea0467522a84
6 N40823910d0634871b921032ac29a4cd6
7 N42845d82b3dd4b5aa680269eb447dbd9
8 N4aaee798d39540928147999ac0927d1a
9 N4d97d2049df0400baae14420b28fdd75
10 N5f0443bae9aa44a7ab0617dd8d6eef92
11 Nd2a9eae463b745b4aadf75dea1acb779
12 Nf34fc6fe53cd45809b2385c586bbd209
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N410bc5dc62074aaa9b81de68856f4b1a
16 schema:citation sg:pub.10.1007/s00280-013-2146-5
17 sg:pub.10.1007/s13300-011-0003-2
18 sg:pub.10.1007/s40264-013-0047-5
19 sg:pub.10.1007/s40264-015-0300-1
20 sg:pub.10.2165/00003495-200767170-00008
21 https://doi.org/10.1002/cpt.60
22 https://doi.org/10.1016/1040-8428(94)00144-i
23 https://doi.org/10.1016/j.vascn.2008.04.001
24 https://doi.org/10.1016/s0163-7258(98)00045-x
25 https://doi.org/10.1016/s1470-2045(15)00021-2
26 https://doi.org/10.1056/nejmra0707704
27 https://doi.org/10.1111/bcp.12443
28 https://doi.org/10.1158/1078-0432.ccr-09-2425
29 https://doi.org/10.1177/0091270007307881
30 https://doi.org/10.1177/0091270011407191
31 https://doi.org/10.1517/14712598.2011.595709
32 https://doi.org/10.1517/14712598.2015.1055243
33 https://doi.org/10.2147/ott.s68558
34 https://doi.org/10.5414/cp202337
35 schema:datePublished 2016-08
36 schema:datePublishedReg 2016-08-01
37 schema:description PURPOSE: Necitumumab is a second-generation, recombinant, human immunoglobulin G1 monoclonal antibody that blocks the ligand binding site of the epidermal growth factor receptor. The primary objective of this phase 2 study, conducted in accordance with International Conference on Harmonisation E14 guidance, was to determine the effect of necitumumab treatment on QT/QTc interval in patients with advanced solid tumors. METHODS: Patients received necitumumab monotherapy at an absolute dose of 800 mg, once per week for each 6-week cycle. Triplicate electrocardiogram readings were taken at pretreatment (baseline) and then weekly at multiple timepoints that were time-matched with blood samples to determine necitumumab concentrations. RESULTS: Seventy-five patients received treatment. Overall, the upper bound of the two-sided 90 % confidence interval for mean change from baseline in QTc in cycle 1 did not exceed 10 ms. No patients had a mean QTcF interval >500 ms, and no patients had an increase of >60 ms. Necitumumab concentration-QTc analysis also showed that necitumumab is unlikely to cause QTc prolongation. CONCLUSIONS: The results demonstrate lack of effect of necitumumab on the QTc interval in heavily pretreated patients with advanced solid tumors, suggesting that QT prolongation is not a major safety concern for necitumumab at the recommended therapeutic dose. The safety profile was consistent with the known safety profile of necitumumab.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N835ca82754b94581905c00d988e9254c
42 Nb35b74b7d9aa4901b79518507cd97ff9
43 sg:journal.1088364
44 schema:name Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors
45 schema:pagination 271-280
46 schema:productId N33b7a7fb976046fb9e60d302b53169bb
47 N91b91fed45dc4fb68e78af70b178ce64
48 Nbc61c83b36114fefbdafa4004a4aa84b
49 Ncdf8e3f9c559445188f3abfe4ab26fe2
50 Nd4a200669eb447559ba4e261c5b4505e
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010329834
52 https://doi.org/10.1007/s00280-016-3074-y
53 schema:sdDatePublished 2019-04-11T12:26
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N0460aee651e548879a517cda97b7ed5f
56 schema:url https://link.springer.com/10.1007%2Fs00280-016-3074-y
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N0460aee651e548879a517cda97b7ed5f schema:name Springer Nature - SN SciGraph project
61 rdf:type schema:Organization
62 N06a3773d3517421db6cc19772f929a05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Adult
64 rdf:type schema:DefinedTerm
65 N1092b9d9ed25431bbfe3ece0e50b2606 rdf:first sg:person.012404342477.52
66 rdf:rest Nb5d9ce5fcfcb429f89fba4c30e5dbf4d
67 N1a6228dbbc9449f788626581c7377a09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Antineoplastic Agents
69 rdf:type schema:DefinedTerm
70 N210c77c77d164fdd91e8c0af462bc673 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Electrocardiography
72 rdf:type schema:DefinedTerm
73 N26580c42c839434bb0bba70b1180918e rdf:first sg:person.011040661365.07
74 rdf:rest N83c9b75d33874086854c35f2be275657
75 N27e431d80b4846c6a7e9dd42cc4e8e73 rdf:first sg:person.01072502357.79
76 rdf:rest Na5db9cc17dd74f1fbd141361b3fb0896
77 N31a8b70616034e4dab6860c930c7dae3 rdf:first sg:person.0602351767.21
78 rdf:rest Ne52ed82b595d4afc90f71d9e3ddeef57
79 N33b7a7fb976046fb9e60d302b53169bb schema:name nlm_unique_id
80 schema:value 7806519
81 rdf:type schema:PropertyValue
82 N347ca019343f4aae8b6560d97c9ecf06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Neoplasms
84 rdf:type schema:DefinedTerm
85 N3ba3d8a351a74389b754ea0467522a84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Humans
87 rdf:type schema:DefinedTerm
88 N40823910d0634871b921032ac29a4cd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Female
90 rdf:type schema:DefinedTerm
91 N40af16c594764e089646af16567cfbe6 schema:name Eli Lilly and Company, Solna, Sweden
92 rdf:type schema:Organization
93 N410bc5dc62074aaa9b81de68856f4b1a rdf:first sg:person.015706665604.37
94 rdf:rest N27e431d80b4846c6a7e9dd42cc4e8e73
95 N42845d82b3dd4b5aa680269eb447dbd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Long QT Syndrome
97 rdf:type schema:DefinedTerm
98 N4aaee798d39540928147999ac0927d1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Middle Aged
100 rdf:type schema:DefinedTerm
101 N4d97d2049df0400baae14420b28fdd75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Aged
103 rdf:type schema:DefinedTerm
104 N5ec4bc78e8864f6f80f476909d116a12 rdf:first sg:person.015756422325.11
105 rdf:rest N1092b9d9ed25431bbfe3ece0e50b2606
106 N5f0443bae9aa44a7ab0617dd8d6eef92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Antibodies, Monoclonal
108 rdf:type schema:DefinedTerm
109 N7d85530bac09490bb4800b9feb5d1a6b rdf:first sg:person.011443672525.44
110 rdf:rest N31a8b70616034e4dab6860c930c7dae3
111 N835ca82754b94581905c00d988e9254c schema:issueNumber 2
112 rdf:type schema:PublicationIssue
113 N83c9b75d33874086854c35f2be275657 rdf:first sg:person.015161041725.23
114 rdf:rest N5ec4bc78e8864f6f80f476909d116a12
115 N8e885675a17e4548a47d65bdb8ec30da rdf:first sg:person.01053122403.86
116 rdf:rest N7d85530bac09490bb4800b9feb5d1a6b
117 N91b91fed45dc4fb68e78af70b178ce64 schema:name readcube_id
118 schema:value 31365caad092f7b8d0c654eddcd4d22b859a4974b0fe0d40bf9b880e1eb0e6ab
119 rdf:type schema:PropertyValue
120 Na5db9cc17dd74f1fbd141361b3fb0896 rdf:first sg:person.0606761270.07
121 rdf:rest N26580c42c839434bb0bba70b1180918e
122 Nb35b74b7d9aa4901b79518507cd97ff9 schema:volumeNumber 78
123 rdf:type schema:PublicationVolume
124 Nb5d9ce5fcfcb429f89fba4c30e5dbf4d rdf:first sg:person.0632743041.51
125 rdf:rest N8e885675a17e4548a47d65bdb8ec30da
126 Nbc61c83b36114fefbdafa4004a4aa84b schema:name pubmed_id
127 schema:value 27312733
128 rdf:type schema:PropertyValue
129 Ncdf8e3f9c559445188f3abfe4ab26fe2 schema:name doi
130 schema:value 10.1007/s00280-016-3074-y
131 rdf:type schema:PropertyValue
132 Nd2a9eae463b745b4aadf75dea1acb779 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Aged, 80 and over
134 rdf:type schema:DefinedTerm
135 Nd4a200669eb447559ba4e261c5b4505e schema:name dimensions_id
136 schema:value pub.1010329834
137 rdf:type schema:PropertyValue
138 Ne52ed82b595d4afc90f71d9e3ddeef57 rdf:first sg:person.012616064757.23
139 rdf:rest rdf:nil
140 Nf34fc6fe53cd45809b2385c586bbd209 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
147 schema:name Clinical Sciences
148 rdf:type schema:DefinedTerm
149 sg:journal.1088364 schema:issn 0344-5704
150 1432-0843
151 schema:name Cancer Chemotherapy and Pharmacology
152 rdf:type schema:Periodical
153 sg:person.01053122403.86 schema:affiliation https://www.grid.ac/institutes/grid.418786.4
154 schema:familyName Mitchell
155 schema:givenName Malcolm I.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053122403.86
157 rdf:type schema:Person
158 sg:person.01072502357.79 schema:affiliation https://www.grid.ac/institutes/grid.488747.0
159 schema:familyName Powderly
160 schema:givenName John
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072502357.79
162 rdf:type schema:Person
163 sg:person.011040661365.07 schema:affiliation https://www.grid.ac/institutes/grid.239578.2
164 schema:familyName Shepard
165 schema:givenName Dale R.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011040661365.07
167 rdf:type schema:Person
168 sg:person.011443672525.44 schema:affiliation https://www.grid.ac/institutes/grid.435900.b
169 schema:familyName Grau
170 schema:givenName Gerrit
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011443672525.44
172 rdf:type schema:Person
173 sg:person.012404342477.52 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
174 schema:familyName Chao
175 schema:givenName Grace Yi
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012404342477.52
177 rdf:type schema:Person
178 sg:person.012616064757.23 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
179 schema:familyName LoRusso
180 schema:givenName Patricia
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012616064757.23
182 rdf:type schema:Person
183 sg:person.015161041725.23 schema:affiliation N40af16c594764e089646af16567cfbe6
184 schema:familyName Wallin
185 schema:givenName Johan
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015161041725.23
187 rdf:type schema:Person
188 sg:person.015706665604.37 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
189 schema:familyName Smith
190 schema:givenName David C.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015706665604.37
192 rdf:type schema:Person
193 sg:person.015756422325.11 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
194 schema:familyName Chaudhary
195 schema:givenName Archana
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015756422325.11
197 rdf:type schema:Person
198 sg:person.0602351767.21 schema:affiliation https://www.grid.ac/institutes/grid.435900.b
199 schema:familyName Kurek
200 schema:givenName Raffael
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602351767.21
202 rdf:type schema:Person
203 sg:person.0606761270.07 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
204 schema:familyName Lee
205 schema:givenName James J.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606761270.07
207 rdf:type schema:Person
208 sg:person.0632743041.51 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
209 schema:familyName Ng
210 schema:givenName Wee Teck
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632743041.51
212 rdf:type schema:Person
213 sg:pub.10.1007/s00280-013-2146-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039786526
214 https://doi.org/10.1007/s00280-013-2146-5
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/s13300-011-0003-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051296505
217 https://doi.org/10.1007/s13300-011-0003-2
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s40264-013-0047-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046942550
220 https://doi.org/10.1007/s40264-013-0047-5
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s40264-015-0300-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025247766
223 https://doi.org/10.1007/s40264-015-0300-1
224 rdf:type schema:CreativeWork
225 sg:pub.10.2165/00003495-200767170-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034984109
226 https://doi.org/10.2165/00003495-200767170-00008
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1002/cpt.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001089388
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/1040-8428(94)00144-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1027064147
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.vascn.2008.04.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001315364
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0163-7258(98)00045-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036450024
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1470-2045(15)00021-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025750831
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmra0707704 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013325677
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1111/bcp.12443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029424155
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1158/1078-0432.ccr-09-2425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005648183
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1177/0091270007307881 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010317390
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1177/0091270011407191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015032956
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1517/14712598.2011.595709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067588473
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1517/14712598.2015.1055243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589107
251 rdf:type schema:CreativeWork
252 https://doi.org/10.2147/ott.s68558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006743397
253 rdf:type schema:CreativeWork
254 https://doi.org/10.5414/cp202337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072834501
255 rdf:type schema:CreativeWork
256 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
257 schema:name University of Michigan, 1500 E Medical Center Drive SPC 5913, 48109, Ann Arbor, MI, USA
258 rdf:type schema:Organization
259 https://www.grid.ac/institutes/grid.21925.3d schema:alternateName University of Pittsburgh
260 schema:name University of Pittsburgh, Pittsburgh, PA, USA
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.239578.2 schema:alternateName Cleveland Clinic
263 schema:name Cleveland Clinic Foundation, Cleveland, OH, USA
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.417540.3 schema:alternateName Eli Lilly (United States)
266 schema:name Eli Lilly and Company, Indianapolis, IN, USA
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.418786.4 schema:alternateName Eli Lilly (United Kingdom)
269 schema:name Eli Lilly and Company, Windlesham, Surrey, UK
270 rdf:type schema:Organization
271 https://www.grid.ac/institutes/grid.4280.e schema:alternateName National University of Singapore
272 schema:name Eil Lilly-NUS, Singapore, Singapore
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.435900.b schema:alternateName Eli Lilly (Germany)
275 schema:name Eli Lilly and Company, Bad Homburg, Germany
276 rdf:type schema:Organization
277 https://www.grid.ac/institutes/grid.47100.32 schema:alternateName Yale University
278 schema:name Yale University, New Haven, CT, USA
279 rdf:type schema:Organization
280 https://www.grid.ac/institutes/grid.488747.0 schema:alternateName Carolina BioOncology Institute
281 schema:name Carolina BioOncology Institute, Huntersville, NC, USA
282 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...